Inversion Deals Aren’t Dead, They’re Just More Low-Key: Real M&A
This article is for subscribers only.
Tax inversions aren’t dead yet.
The U.S. Treasury Department took steps in September to make it harder for American companies to pursue overseas mergers that move their legal addresses abroad and produce tax benefits. The new rules put a damper on the practice and led drugmaker AbbVie Inc. to scrap its more than $50 billion deal for Shire Plc.